Evofem Biosciences, Inc. financial data

Symbol
EVFM on OTC
Location
San Diego, CA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 13 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 12% % 11%
Quick Ratio 2.4% % 31%
Debt-to-equity -116% % -3.8%
Return On Equity 7.6% % -33%
Return On Assets -34% % 46%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 126,685,925 shares 26%
Common Stock, Shares, Outstanding 123,956,354 shares 24%
Entity Public Float $900,000 USD -53%
Common Stock, Value, Issued $12,000 USD 20%
Weighted Average Number of Shares Outstanding, Basic 119,578,093 shares 24%
Weighted Average Number of Shares Outstanding, Diluted 119,578,093 shares 24%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $17,726,000 USD 3.7%
Research and Development Expense $1,845,000 USD -37%
Selling and Marketing Expense $9,822,000 USD 2.3%
General and Administrative Expense $9,718,000 USD -15%
Costs and Expenses $18,702,000 USD -31%
Operating Income (Loss) $976,000 USD 90%
Nonoperating Income (Expense) $4,455,000 USD -311%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $5,431,000 USD 32%
Income Tax Expense (Benefit) $4,000 USD 50%
Net Income (Loss) Attributable to Parent $5,434,000 USD 32%
Earnings Per Share, Basic 0 USD/shares -99%
Earnings Per Share, Diluted 0 USD/shares -100%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $221,000 USD
Accounts Receivable, after Allowance for Credit Loss, Current $4,435,000 USD -18%
Inventory, Net $1,684,000 USD 15%
Assets, Current $7,918,000 USD -7.7%
Property, Plant and Equipment, Net $420,000 USD -64%
Operating Lease, Right-of-Use Asset $195,000 USD 54%
Other Assets, Noncurrent $36,000 USD 0%
Assets $13,807,000 USD -42%
Accounts Payable, Current $11,624,000 USD -31%
Employee-related Liabilities, Current $3,609,000 USD 12%
Accrued Liabilities, Current $1,363,000 USD -73%
Contract with Customer, Liability, Current $4,500,000 USD
Liabilities, Current $78,186,000 USD 2.5%
Operating Lease, Liability, Noncurrent $72,000 USD 620%
Liabilities $83,976,000 USD -6.8%
Accumulated Other Comprehensive Income (Loss), Net of Tax $6,718,000 USD -294%
Retained Earnings (Accumulated Deficit) $900,176,000 USD -0.62%
Stockholders' Equity Attributable to Parent $75,066,000 USD -5.9%
Liabilities and Equity $13,807,000 USD -42%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $560,000 USD 355%
Net Cash Provided by (Used in) Financing Activities $135,000 USD
Net Cash Provided by (Used in) Investing Activities $57,000 USD -307%
Common Stock, Shares Authorized 3,000,000,000 shares 0%
Common Stock, Shares, Issued 123,956,354 shares 24%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $368,000 USD 238%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $840,000 USD 16%
Deferred Tax Assets, Valuation Allowance $146,415,000 USD 1.1%
Deferred Tax Assets, Gross $146,448,000 USD 1%
Operating Lease, Liability $196,000 USD 56%
Depreciation $6,000 USD -50%
Payments to Acquire Property, Plant, and Equipment $14,000 USD 367%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $10,445,000 USD -12%
Lessee, Operating Lease, Liability, to be Paid $213,000 USD 60%
Property, Plant and Equipment, Gross $532,000 USD -72%
Operating Lease, Liability, Current $124,000 USD 6.9%
Lessee, Operating Lease, Liability, to be Paid, Year Two $52,000 USD 550%
Lessee, Operating Lease, Liability, to be Paid, Year One $127,000 USD 48%
Operating Lease, Weighted Average Discount Rate, Percent 0.12 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $17,000 USD 143%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5,000,000 shares 0%
Unrecognized Tax Benefits $3,043,000 USD -0.26%
Operating Lease, Payments $64,000 USD 0%
Additional Paid in Capital $831,816,000 USD 0.77%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets $80,000 USD -73%
Share-based Payment Arrangement, Expense $312,000 USD -66%
Interest Expense $577,000 USD 2.3%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%